Literature DB >> 28289575

Assessment of factors associated with prominent changes in blood pressure during an early mobilization protocol for patients with acute ischemic stroke after mechanical thrombectomy.

Maiko Yagi1, Sato Watanabe1, Chika Kondo2, Yukiko Kaihoko1, Koji Endo1, Fumio Miyashita3, Tatsuro Takada4, Toshihiro Ueda4.   

Abstract

OBJECTIVE: To assess factors associated with changes in blood pressure during early mobilization protocol for patients with acute ischemic stroke who were treated with mechanical thrombectomy.
DESIGN: Retrospective observational study.
METHOD: We analyzed patients with acute ischemic stroke who were treated with mechanical thrombectomy (MT group, n=60) and patients who received conservative medical management (control group, n=60) matched by age and National Institute Health of Stroke Score at admission from April 2009 to July 2014. The proportion of patients with prominent blood pressure change during an early mobilization protocol was compared between the MT group and control group. Factors associated with prominent blood pressure change were also analyzed using multivariable logistic regression analysis. RESULT: The deviation in blood pressure response was much more significant in the MT than control group (13.3 vs. 1.7%, p<0.016). Logistic regression analysis showed the interval from admission to being able to sit in a wheelchair associated with prominent changes in blood pressure (odds ratio, 1.604; 95% confidence interval, 1.196-2.150; p<0.002).
CONCLUSION: Our results showed that prominent changes in blood pressure during an early mobilization protocol can occur easily in patients with acute ischemic stroke after mechanical thrombectomy.

Entities:  

Keywords:  early mobilization protocol; ischemic stroke; mechanical thrombectomy

Year:  2016        PMID: 28289575      PMCID: PMC5342961          DOI: 10.1298/ptr.e9885

Source DB:  PubMed          Journal:  Phys Ther Res        ISSN: 2189-8448


  16 in total

1.  Adaptation of the left heart, cerebral and femoral arteries, and jugular and femoral veins during short- and long-term head-down tilt and spaceflights.

Authors:  P Arbeille; G Fomina; J Roumy; I Alferova; N Tobal; S Herault
Journal:  Eur J Appl Physiol       Date:  2001-12       Impact factor: 3.078

Review 2.  Acute stroke: evaluation and treatment.

Authors:  M Sharma; H Clark; T Armour; G Stotts; R Coté; M D Hill; A M Demchuck; D Moher; C Garritty; F Yazdi; K Lumely-Leger; M Murdock; M Sampson; N Barrowman; G Lewin
Journal:  Evid Rep Technol Assess (Summ)       Date:  2005-07

3.  Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

Authors:  Nils Wahlgren; Niaz Ahmed; Antoni Dávalos; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Sonja Kuelkens; Vincent Larrue; Kennedy R Lees; Risto O Roine; Lauri Soinne; Danilo Toni; Geert Vanhooren
Journal:  Lancet       Date:  2007-01-27       Impact factor: 79.321

4.  Antihypertensive therapy and orthostatic hemodynamic responses in acute stroke.

Authors:  Barnabas Panayiotou; Saad Saeed; Martin Fotherby; Kareem Al-Allaf; Peter Crome
Journal:  Am J Hypertens       Date:  2002-01       Impact factor: 2.689

5.  The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset.

Authors:  Jeffrey L Saver; Eric E Smith; Gregg C Fonarow; Mathew J Reeves; Xin Zhao; Daiwai M Olson; Lee H Schwamm
Journal:  Stroke       Date:  2010-06-03       Impact factor: 7.914

6.  Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.

Authors:  Michael D Hill; Alastair M Buchan
Journal:  CMAJ       Date:  2005-05-10       Impact factor: 8.262

7.  Very early mobilization in stroke patients treated with intravenous recombinant tissue plasminogen activator.

Authors:  Scott M Arnold; Maryane Dinkins; Lesia H Mooney; William D Freeman; Bhupendra Rawal; Michael G Heckman; Olivia A Davis
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-04-11       Impact factor: 2.136

8.  Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals.

Authors:  Phillip A Scott; Zhenzhen Xu; William J Meurer; Shirley M Frederiksen; Mary N Haan; Michael W Westfall; Sandip U Kothari; Lewis B Morgenstern; John D Kalbfleisch
Journal:  Stroke       Date:  2010-08-12       Impact factor: 7.914

9.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.

Authors:  Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Blaise W Baxter; Thomas G Devlin; Demetrius K Lopes; Vivek K Reddy; Richard du Mesnil de Rochemont; Oliver C Singer; Reza Jahan
Journal:  N Engl J Med       Date:  2015-04-17       Impact factor: 91.245

10.  Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.

Authors:  Maher Saqqur; Ken Uchino; Andrew M Demchuk; Carlos A Molina; Zsolt Garami; Sergio Calleja; Naveed Akhtar; Finton O Orouk; Abdul Salam; Ashfaq Shuaib; Andrei V Alexandrov
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.